Vanguard Group’s Rallybio RLYB Stock Holding History
Bought
Maintained
Sold
Other funds holding RLYB
AIIC
JJ
5VM
TGA
PBPIA
AC
CPX
Vanguard Group's RLYB Position: Q4 2025 in Review
Vanguard Group increased its Rallybio (RLYB) stake by 1.7% in Q4 2025, buying an estimated $10.7K and bringing the position to 127,031 shares worth $697K. The position accounts for ﹤0.01% of the portfolio, ranked #3865.
Vanguard Group first reported a position in RLYB in Q3 2021 and has held it in 18 quarters since. The position peaked at $11.6M in Q3 2022. 46 funds tracked by Wall St. Rank hold RLYB as of Q4 2025.
- Vanguard Group held 127,031 shares of Rallybio worth $697K as of Q4 2025.
- Vanguard Group bought 2,078 Rallybio shares in Q4 2025, an estimated $10.7K.
- Rallybio made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #3865 holding.
- Vanguard Group first reported a position in Rallybio in Q3 2021 and has held it in 18 quarters since.
- Vanguard Group's Rallybio position peaked at $11.6M in Q3 2022.
- 46 funds tracked by Wall St. Rank held Rallybio as of Q4 2025.
Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.